I'm tired of hearing this. Time and time again over the last 6+months we've heard straight from Ed that this company is no longer an R&D company. Due to Asepticsure and it's potential, MZEI has adapted and changed it structure and purpose. Now, it still eventually plans to get into the viral blood game with the revenues from the various sectors Asepticsure will pierce, but Medizone isn't a R&D company anymore.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.